Cutaneous heat: A potential environmental factor in the development of melasma

Cosmetic Dermatology

Volumn 17, Issue 6, 2004, Pages 387-390

  Willis, Isaac ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FLUOCINOLONE ACETONIDE; HYDROQUINONE; RETINOIC ACID; SUNSCREEN;

CHLOASMA; ENVIRONMENTAL FACTOR; ENVIRONMENTAL TEMPERATURE; HEAT; HEREDITY; HISTOPATHOLOGY; HUMAN; PATIENT EDUCATION; PREVENTIVE MEDICINE; RACE DIFFERENCE; REVIEW; SKIN TEMPERATURE; THERMAL EXPOSURE; ULTRAVIOLET RADIATION;

EID: 2942679430     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Grimes PE. Melasma. Etiologic and therapeutic considerations, Arch Dermatol. 1995;131:1453-1457.
2. Mosher DB, Fitzpatrick PB, Ortonne J-P, et al. Hypomelanoses and hypermelanoses, In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. Vol 1. New York, NY: McGraw-Hill; 1999:945-1017.
3. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol. 1986;15: 894-899.
4. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18:91-98.
5. Vázquez M, Maldonado H, Benmamán C, et al. Melasma in men. A clinical and histologic study. Int J Dermatol. 1988;27:25-27.
6. Sialy R, Hassan I, Kaur I, et al. Melasma in men: a hormonal profile. J Dermatol. 2000;27:64-65.
7. Johnston GA, Sviland L, McLelland J. Melasma of the arms associated with hormone replacement therapy [letter]. Br J Dermatol. 1998;139:932.
8. Varma S, Roberts DL, Melasma of the arms associated with hormone replacement therapy [letter]. Br J Dermatol. 1999;141:592.
9. Jimbow K, Quevedo WC Jr, Prota G, et al. Biology of melanocytes, In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. Vol 1. New York, NY: McGraw-Hill; 1999:192-218.
10. Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228-237.
11. Im S, Kim J, On WY, et al. Increased expression of α-melanocyte- stimulating hormone in the lesional skin of melasma [letter]. Br J Dermatol. 2002;146:165-167.
12. Wenger CB. Thermoregulation. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. Vol 1. New York, NY: McGraw-Hill; 1999:175-183.
13. Moloney FJ, Collins S, Murphy GM. Sunscreens: safety, efficacy and appropriate use. Am J Clin Dermatol. 2002;3:185-191.
14. Taylor SC, Skin of color biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol. 2002;46(supp 2):S41-S62.
15. Ruiz-Esparza J. Medical applications of resurfacing lasers. Adv Dermatol. 2000;16:453-474.
16. Hurley ME, Guevara IL, Gonzales RM, et al. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol. 2002;138:1578-1582.
17. Guevara IL, Pandya AG. Melasma treated with hydroquinone, tretinoin, and a fluorinated steroid. Int J Dermatol. 2001;40: 212-215,
18. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111:40-48.
19. Taylor SC, Torok H, Jones T, et al. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72:67-72.